| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Medical Genetics, University of Helsinki, Helsinki, Finland FIN-00014 [W. E-R., S. K.]; Department of Human Genetics, National Research Center, Giza, Egypt [W. E-R.]; Department of Medicine, University of Virginia Health Sciences Center, Charlottesville, VA 22906-0013 [J. C. H., S. M. P.]; Department of Pathology, University of Virginia Health Sciences Center, Charlottesville, VA 22908 [E-R. H., H. F. F.]; and Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana 46202 [O. W. C.]
The genetic alterations underlying the development of gastric and gastro-esophageal carcinoma remain largely undefined. DNA copy number changes were determined by comparative genomic hybridization in eight xenografts of proximal gastric and gastro-esophageal junction adenocarcinomas of the intestinal type. All tumors exhibited DNA copy number changes, with a total of 139 changes detected (range, 11–24 per tumor; mean = 17), indicating numerous and widespread alterations within these cancers. Gains (65%) in DNA copy number were more frequent than losses (35%).
Our most striking finding was gain (all eight cases) or high-level amplification (four cases) in 20q, with a minimal common overlapping region at 20q13. Other frequent gains were observed at 6p, 7q, and 17q (six cases each) and at 1q, 2q, and 8q (five cases each). Frequent losses were observed at 4q and 5q (six cases each) and at 9p (five cases). No differences in DNA copy number changes were seen in tumors arising from the gastro-esophageal junction compared to those of the proximal stomach. The presence of common and consistent DNA copy number changes in these tumors implicate a number of chromosomal regions that may harbor important genes that are involved in tumorigenesis of the proximal stomach and gastro-esophageal junction.
1 This work was supported in part by NIH Grant 1R29CA6790001 and a Foundation American Gastroenterological Association Research Scholarship Award.
2 To whom requests for reprints should be addressed, at University of Virginia Health Sciences Center, Box 10013, Charlottesville, VA 22906-0013.
Received 9/30/97. Accepted 11/12/97.
This article has been cited by other articles:
|
|
 |
|
  P. L. Andersen, H. Zhou, L. Pastushok, T. Moraes, S. McKenna, B. Ziola, M. J. Ellison, V. M. Dixit, and W. Xiao Distinct regulation of Ubc13 functions by the two ubiquitin-conjugating enzyme variants Mms2 and Uev1A J. Cell Biol., August 29, 2005; 170(5): 745 - 755. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Imoto, Z.-Q. Yang, A. Pimkhaokham, H. Tsuda, Y. Shimada, M. Imamura, M. Ohki, and J. Inazawa Identification of cIAP1 As a Candidate Target Gene within an Amplicon at 11q22 in Esophageal Squamous Cell Carcinomas Cancer Res., September 1, 2001; 61(18): 6629 - 6634. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. van Dekken, J. C. Alers, P. H. J. Riegman, C. Rosenberg, H. W. Tilanus, and K. Vissers Molecular Cytogenetic Evaluation of Gastric Cardia Adenocarcinoma and Precursor Lesions Am. J. Pathol., June 1, 2001; 158(6): 1961 - 1967. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. H. J. Riegman, K. J. Vissers, J. C. Alers, E. Geelen, W. C. J. Hop, H. W. Tilanus, and H. van Dekken Genomic Alterations in Malignant Transformation of Barrett's Esophagus Cancer Res., April 1, 2001; 61(7): 3164 - 3170. [Abstract] [Full Text]
|
|
|
|
|
|
Y. H. Kim, N.-G. Kim, J. G. Lim, C. Park, and H. Kim Chromosomal Alterations in Paired Gastric Adenomas and Carcinomas Am. J. Pathol., February 1, 2001; 158(2): 655 - 662. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.’e. El-Rifai, D. Kamel, M. L. Larramendy, S. Shoman, Y. Gad, S. Baithun, M. El-Awady, S. Eissa, H. Khaled, S. Soloneski, et al. DNA Copy Number Changes in Schistosoma-Associated and Non-Schistosoma-Associated Bladder Cancer Am. J. Pathol., March 1, 2000; 156(3): 871 - 878. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Walch, H. F. Zitzelsberger, J. Bruch, G. Keller, D. Angermeier, M. M. Aubele, J. Mueller, H. Stein, H. Braselmann, J. R. Siewert, et al. Chromosomal Imbalances in Barrett’s Adenocarcinoma and the Metaplasia-Dysplasia-Carcinoma Sequence Am. J. Pathol., February 1, 2000; 156(2): 555 - 566. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Llor, M. S. Serfas, W. Bie, V. Vasioukhin, M. Polonskaia, J. Derry, C. M. Abbott, and A. L. Tyner BRK/Sik Expression in the Gastrointestinal Tract and in Colon Tumors Clin. Cancer Res., July 1, 1999; 5(7): 1767 - 1777. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. G. Paulson, P. C. Galipeau, and B. J. Reid Loss of Heterozygosity Analysis Using Whole Genome Amplification, Cell Sorting, and Fluorescence-Based PCR Genome Res., May 1, 1999; 9(5): 482 - 491. [Abstract] [Full Text]
|
|
|
|
|
|
C. A. Rumpel, S. M. Powell, and C. A. Moskaluk Mapping of Genetic Deletions on the Long Arm of Chromosome 4 in Human Esophageal Adenocarcinomas Am. J. Pathol., May 1, 1999; 154(5): 1329 - 1334. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. van Dekken, E. Geelen, W. N. M. Dinjens, B. P. L. Wijnhoven, H. W. Tilanus, H. J. Tanke, and C. Rosenberg Comparative Genomic Hybridization of Cancer of the Gastroesophageal Junction: Deletion of 14Q31-32.1 Discriminates between Esophageal (Barrett's) and Gastric Cardia Adenocarcinomas Cancer Res., February 1, 1999; 59(3): 748 - 752. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Zamostiano, A. Pinhasov, E. Gelber, R. A. Steingart, E. Seroussi, E. Giladi, M. Bassan, Y. Wollman, H. J. Eyre, J. C. Mulley, et al. Cloning and Characterization of the Human Activity-dependent Neuroprotective Protein J. Biol. Chem., January 5, 2001; 276(1): 708 - 714. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
